IL28B polymorphism,Explanation for Different Responses to Therapy in Hepatitis C Patients
| Author | Heidar Sharafi | en |
| Author | Seyed Moayed Alavian | en |
| Orcid | Seyed Moayed Alavian [0000-0002-4443-6602] | en |
| Issued Date | 2011-12-31 | en |
| Abstract | Implication for health policy/practice/research/medical education:This article focuses on impact of IL28B polymorphisms on hepatitis C outcomes. This study is recommended to clinicians and researchers in the field of viral hepatitis. Please cite this paper as:Sharafi H, Alavian SM. IL28B polymorphism, explanation for Different Responses to Therapy in Hepatitis C patients. HepatMon. 2011; 11(12):958-9. DoI: 10.5812/kowsar.1735143X.794 | en |
| DOI | https://doi.org/10.5812/kowsar.1735143X.794 | en |
| Keyword | Polymorphism | en |
| Keyword | Genetic | en |
| Keyword | Hepatitis C | en |
| Keyword | IL28B Protein | en |
| Keyword | Human | en |
| Publisher | Brieflands | en |
| Title | IL28B polymorphism,Explanation for Different Responses to Therapy in Hepatitis C Patients | en |
| Type | Editorial | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 70374-pdf.pdf
- Size:
- 786.64 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF